ARS Pharma (SPRY) stock gains as Japan approved the company's neffy nasal spray for allergy, marketed with Alfresa Holidings (ALFRY) (ARHCY), Read more here.
ARS Pharma stock rises on Japan nod for neffy (SPRY:NASDAQ)
ARS Pharma (SPRY) stock gains as Japan approved the company's neffy nasal spray for allergy, marketed with Alfresa Holidings (ALFRY) (ARHCY), Read more here.